Original Article
Development of a haematological indices-based nomogram for prognostic prediction and immunotherapy response assessment in primary pulmonary lymphoepithelioma-like carcinoma patients
Translational Lung Cancer Research
2024;
13
(3)
:453-464
.
(29 March 2024)
Outcomes of extracranial stereotactic body radiation therapy for induced oligometastatic non-small cell lung cancer on novel systemic therapy
Translational Lung Cancer Research
2024;
13
(3)
:465-474
.
(29 March 2024)
Revisiting the impact of clinicopathologic characteristics in PD-L1 profile in a large cohort of non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(3)
:475-490
.
(29 March 2024)
Additional local therapy before disease progression for EGFR-mutated advanced lung cancer: a systematic review and meta-analysis
Translational Lung Cancer Research
2024;
13
(3)
:491-502
.
(29 March 2024)
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel
Translational Lung Cancer Research
2024;
13
(3)
:503-511
.
(29 March 2024)
A cross-trait study of lung cancer and its related respiratory diseases based on large-scale exome sequencing population
Translational Lung Cancer Research
2024;
13
(3)
:512-525
.
(29 March 2024)
Efficacy and safety of first-line PD-L1/PD-1 inhibitors in limited-stage small cell lung cancer: a multicenter propensity score matched retrospective study
Translational Lung Cancer Research
2024;
13
(3)
:526-539
.
(29 March 2024)
Margin quality analysis for wedge resection of lung cancer and construction of a predictive model
Translational Lung Cancer Research
2024;
13
(3)
:540-551
.
(29 March 2024)
Regulatory role of the miR-142-3p/CDC25C axis in modulating autophagy in non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(3)
:552-572
.
(29 March 2024)
A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data
Translational Lung Cancer Research
2024;
13
(3)
:573-586
.
(29 March 2024)
The role of RASA2 in predicting radioresistance in lung cancer through regulation of p53
Translational Lung Cancer Research
2024;
13
(3)
:587-602
.
(29 March 2024)
Surgical Technique
A simple and safe surgical technique for nonpalpable lung tumors: One-stop Solution for a nonpalpable lung tumor, Marking, Resection, and Confirmation of the surgical margin in a Hybrid operating room (OS-MRCH)
Translational Lung Cancer Research
2024;
13
(3)
:603-611
.
(29 March 2024)
Review Article
The use of intravenous indocyanine green in minimally invasive segmental lung resections: a systematic review
Translational Lung Cancer Research
2024;
13
(3)
:612-622
.
(29 March 2024)
Promising preclinical models for lung cancer research—lung cancer organoids: a narrative review
Translational Lung Cancer Research
2024;
13
(3)
:623-634
.
(29 March 2024)
Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review
Translational Lung Cancer Research
2024;
13
(3)
:635-653
.
(29 March 2024)
Case Report
Robot-assisted minimally invasive bronchial resection with primary anastomosis for schwannoma arising from left main bronchus: a case report
Translational Lung Cancer Research
2024;
13
(3)
:654-665
.
(29 March 2024)
Hyperprogressive disease under anti-PD-1 rechallenge after initial response to anti-PD-1 treatment for non-small cell lung cancer: a case report
Translational Lung Cancer Research
2024;
13
(3)
:666-672
.
(29 March 2024)
Editorial Commentary
Novel immunotherapy combinations in neoadjuvant non-small cell lung cancer (NSCLC): a better chance at cure?
Translational Lung Cancer Research
2024;
13
(3)
:673-677
.
(29 March 2024)
Challenges and considerations in the immunotherapy of DLL3-positive small-cell lung cancer using IL-18 armoured chimeric antigen receptor T-cells
Translational Lung Cancer Research
2024;
13
(3)
:678-683
.
(29 March 2024)
Oncogene alterations in non-small cell lung cancer with FGFR1 amplification—novel approach to stratify patients who benefit from FGFR inhibitors
Translational Lung Cancer Research
2024;
13
(3)
:684-688
.
(29 March 2024)
Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target
Translational Lung Cancer Research
2024;
13
(3)
:689-693
.
(29 March 2024)
DLL3-targeted CAR T-cell therapy in pre-clinical models for small cell lung cancer: safety, efficacy, and challenges
Translational Lung Cancer Research
2024;
13
(3)
:694-698
.
(29 March 2024)
ATM—the gene at the moment in non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(3)
:699-705
.
(29 March 2024)
